5.12.2017 | Ryan Carroll

Niravam official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

The physician should periodically reassess the usefulness of the drug for the individual patient. Demonstrations of the effectiveness of Niravam by systematic clinical study are limited to 4 months in duration for generalized anxiety disorder and 4 to 10 weeks duration for panic disorder; however, patients with panic disorder have been treated on an open basis for up to 8 months without apparent loss of benefit.

Other drugs possibly affect alprazolam metabolism by inhibition of CYP3A [ see Drug Interactions ( 7.6 ) ]

Generic Name: alprazolam Dosage Form: tablet, orally disintegrating.

Consider dose reduction of Niravam during coadministration with the following drugs:

The data cited in the two tables below are estimates of adverse reactions occurring in patients who participated in clinical trials under the following conditions: relatively short duration (four weeks) placebo-controlled clinical studies with dosages up to 4 mg per day of alprazolam (for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety) and short-term (up to ten weeks) placebo-controlled clinical studies with dosages up to 10 mg per day of alprazolam in patients with panic disorder, with or without agoraphobia.

The use of benzodiazepines, including Niravam, may lead to physical and psychological dependence.

Niravam Oral Uses, Side Effects, Interactions, Pictures, Warnings

9.16.2017 | Abigail Miln

Find patient medical information for Niravam Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

l your doctor if your condition persists or worsens.

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Having trouble identifying your pills?

If the tablets are exposed to moisture, they may not work properly. Do not store in the bathroom. After opening the bottle, throw away any cotton that you find inside. Reseal the bottle tightly to prevent moisture from getting into the bottle. Store in a tightly sealed container provided by your pharmacist, at room temperature, away from light and moisture.

Niravam Uses, Side Effects & Warnings

7.14.2017 | Sydney Holmes

Physician reviewed Niravam patient information - includes Niravam description, dosage and directions.

confusion, agitation, hostility, hallucinations;

Selling or giving away this medicine is against the law. Misuse of habit-forming medicine can cause addiction, overdose, or death.

if you are allergic to alprazolam or to other benzodiazepines, such as chlordiazepoxide (Librium), clorazepate (Tranxene), diazepam (Valium), lorazepam (Ativan), or oxazepam (Serax).

Do not use alprazolam if you are pregnant.

Niravam Dosage Guide

6.13.2017 | Abigail Miln

Detailed dosage guidelines and administration information for Niravam (alprazolam). Includes dose adjustments, warnings and precautions.

Panic Disorder sertraline, Xanax, Zoloft, Prozac, alprazolam, clonazepam, fluoxetine, lorazepam, More.

The necessary duration of treatment for panic disorder patients responding to NIRAVAM is unknown.

Niravam orally disintegrating tablets Indications, Side Effects

8.15.2017 | Sydney Holmes

Do NOT use Niravam orally disintegrating tablets if: you are allergic to any ingredient in Niravam orally disintegrating tablets or other benzodiazepines (eg, diazepam) Hydantoins (eg, phenytoin) because the risk of their side effects may be increased and they may decrease Niravam.

Generic Name: alprazolam (al-PRA-zoe-lam) Brand Name: Niravam.

Some medical conditions may interact with Niravam orally disintegrating tablets. l your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:.

provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Data sources include Micromedex (updated July 5th, 2017), Cerner Multum (updated July 13th, 2017), Wolters Kluwer (updated July 5th, 2017) and others.